首页> 中文期刊>医学综述 >非ST段抬高型急性冠状动脉综合征抗栓治疗进展

非ST段抬高型急性冠状动脉综合征抗栓治疗进展

     

摘要

The treatment of non-ST-segment elevation acute coronary syndromes includes medical treat-ment,percutaneous coronary intervention and coronary artery bypass grafting,and antithrombotic therapy sig-nificantly reduces mortality in patients and the incidence of myocardial infarction and disability rate,and im-proving the quality of life of patients. There are two kinds of antithrombotic drugs,antiplatelet and anticoagu-lant drugs. The antiplatelet agents include aspirin,adenosine monophosphate receptor antagonist and platelet membrane glycoprotein antibody antagonist. The anticoagulant drugs consist of heparin,low molecular weight heparin,anti factor Ⅹa inhibitors and the direct thrombin inhibitor etc.%非ST段抬高急性冠状动脉综合征的治疗包括药物治疗、经皮腔内冠状动脉介入治疗和冠状动脉旁路移植术,而抗栓药物治疗大大减少了患者的病死率、心肌梗死发生率及致残率,同时提高患者生活质量。抗栓药物包括抗血小板和抗凝药。其中抗血小板药有阿司匹林、磷酸腺苷受体拮抗剂和血小板膜糖蛋白抗体拮抗剂等;抗凝药有普通肝素和低分子肝素、抗Ⅹa因子抑制药和直接凝血酶抑制剂等。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号